Invention Grant
- Patent Title: Anti-TNF-alpha-antibodies and functional fragments thereof
-
Application No.: US16085565Application Date: 2017-03-16
-
Publication No.: US10759852B2Publication Date: 2020-09-01
- Inventor: Tea Gunde , Sebastian Meyer
- Applicant: Numab Innovation AG
- Applicant Address: CH Waedenswil
- Assignee: Numab Innovation AG
- Current Assignee: Numab Innovation AG
- Current Assignee Address: CH Waedenswil
- Agency: Smith Patent, LLC
- Agent Chalin A. Smith
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6221d49c
- International Application: PCT/EP2017/056227 WO 20170316
- International Announcement: WO2017/158084 WO 20170921
- Main IPC: C07K16/24
- IPC: C07K16/24 ; C12N15/85 ; A61K39/395 ; A61K39/00 ; A61P37/06 ; A61P1/04 ; A61K38/00
Abstract:
The present invention relates to antibody molecules and functional fragments thereof, capable of binding to tumor necrosis factor alpha (TNFα), to processes for their production, and to their therapeutic uses.
Public/Granted literature
- US20190194310A1 ANTI-TNF-ALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF Public/Granted day:2019-06-27
Information query
